EVIDENCE VS HYPE · CREATINE & ENDURANCE
The hype: If creatine gives muscles more energy, it should help you run further, cycle faster and stay strong throughout an endurance race.
The idea makes sense at first glance. Endurance athletes need energy, and many races include hills, accelerations or a sprint finish. But the energy demands of a five-second surge differ from those of an hour at a steady pace. We investigated whether creatine monohydrate improves endurance performance itself, rather than assuming that its reputation in strength training applies to every sport.
The short answer
Creatine has not shown a reliable overall endurance benefit in trained athletes. It may be useful when an event or training programme involves repeated high-intensity efforts, but that is a narrower claim than faster distance running or better aerobic capacity. A possible sprint advantage should not be marketed as proof of a better marathon time.
Why people believe it
Creatine helps replenish the muscle's rapidly available energy supply during demanding contractions. Increasing muscle creatine stores can therefore be relevant to brief, intense efforts. Longer exercise relies heavily on other energy pathways, oxygen delivery and the ability to sustain an appropriate pace. More capacity in one part of the system does not necessarily improve the entire performance.
There are also two different questions hidden in the claim. Does creatine improve a particular test today? Or does it help someone complete higher-quality training and improve months later? Short supplementation experiments can address the first question more readily than the second. Neither question is answered simply by showing that muscle creatine levels increased.
What the evidence says
The pooled endurance result is unconvincing
A 2023 systematic review by Fernández-Landa and colleagues included 13 placebo-controlled studies in trained people. The pooled effect on endurance performance was essentially zero: a standardised difference of −0.07, with a 95% confidence interval from −0.32 to 0.18. Results remained similar in a sensitivity analysis. The search ran to May 2022 and the review protocol was registered.
This estimate does not mean creatine reduces everyone's performance by 7%. Standardised effects combine different measurements. Here the interval includes both modest harm and modest benefit, with no convincing average improvement. It argues against treating creatine as an established endurance enhancer, while leaving room for more specific questions. Read the 2023 systematic review and meta-analysis.
Newer research suggests context matters
A 2026 scoping review mapped 38 randomised trials published between 1996 and 2025 across endurance and mixed-sport settings. Favourable results appeared more often in repeated sprints and high-intensity power tasks. Aerobic outcomes and recovery markers were limited or inconsistent. Some apparent improvements occurred within a group without a clear advantage over placebo.
A scoping review maps a broad research landscape; it does not provide a single pooled effect or establish that every positive result is robust. Its authors declared no conflicts of interest. The useful takeaway is specificity: an intermittent cycling protocol, a swimming sprint and a long steady time trial are different tests, even when all involve endurance athletes. Read the 2026 endurance and mixed-sport scoping review.
An athlete trial shows why plausible benefits need testing
In a 2024 randomised trial, 23 professional under-23 cyclists completed a training camp. Eleven received a recovery drink with 20 g of creatine daily; twelve received the recovery drink alone. Supplementation lasted seven days. Creatine did not provide a performance advantage across the sprint and time-trial measures assessed, or prevent the accompanying increase in fatigue and soreness.
This was a small, short trial in highly trained young cyclists. It cannot settle effects in recreational runners or longer training programmes. It nevertheless directly challenges the assumption that adding a high dose to a recovery drink automatically improves an endurance athlete's training-week performance. The trial dose describes an experiment, not a recommended starting dose. Read Barranco-Gil et al., 2024.
The catch: what these studies cannot establish
Endurance is not one outcome. Time to exhaustion can change without a comparable improvement in a realistic race. A laboratory time trial is usually more relevant to racing, but still does not reproduce weather, tactics or a crowded field. Studies using different tests should not be combined into a confident promise about one event.
Trials also differ in loading protocols, training status, diet and duration. Small samples may miss a modest benefit or exaggerate an apparent one. The 2023 review and 2026 map overlap in their underlying research, so they should not be counted as two entirely independent bodies of evidence. We have not established a dependable long-term race-time improvement or an ideal endurance-specific protocol.
Body mass is another practical consideration. Creatine-related water gain may matter differently to a runner, a hill-climbing cyclist and a swimmer. A supplement that helps a short power effort may offer a less attractive trade-off in a weight-bearing event. This does not mean the water gain is dangerous; it means performance decisions need to consider the whole athlete and event.
What this means for you
If your main goal is a faster long-distance race, prioritise an appropriate training plan, adequate fuelling, recovery and a pacing strategy. Creatine is an optional experiment for a specific need, not a missing essential. An athlete who also performs resistance training or repeated surges has a different reason to consider it from someone seeking a general aerobic boost.
If you try it, use plain monohydrate and evaluate relevant performance and tolerance during training, rather than introducing it immediately before an important event. A sudden change in body mass or digestion could be inconvenient. Seek individual advice if you have kidney disease, another relevant medical condition or medication concerns. Higher doses and proprietary endurance blends do not overcome uncertain evidence.
Explore all Creatine investigations → For the better-supported training claim, see our muscle growth and strength investigation.
Research & Sources
- Fernández-Landa et al. (2023): trained-population endurance systematic review and meta-analysis.
- Wesołowski et al. (2026): endurance and mixed-sport scoping review.
- Barranco-Gil et al. (2024): randomised professional-cyclist trial.
Evidence reviewed: October 2026. This investigation is educational and does not provide individual medical advice. No commercial product was tested or endorsed. Buying guidance and any disclosed affiliate recommendations are separate from this evidence verdict.